National Cancer Institute (NCI): Ovarian Neoplasms trials

The registry lists 105 Ovarian Neoplasms studies with National Cancer Institute (NCI) as lead sponsor. 11 are open to participants now and 41 have results posted.

Early Phase 1 3Phase 1 40Phase 2 48Phase 3 7No phase 15(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• p53 Vaccine for Ovarian CancerTerminatedNCT00001827Phase 2
• Methods in Education for Breast Cancer GeneticsCompletedNCT00001806Phase 3
• A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and CisplatinCompletedNCT00001427Phase 2
• A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian CancerCompletedNCT00001426Phase 2
• A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer PatientsCompletedNCT00001272Phase 1